Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 2.83B | £ 2.23B | £ 2.04B | £ 1.37B | £ 1.01B |
Total Assets | £ 4.70B | £ 3.99B | £ 3.57B | £ 2.87B | £ 2.64B |
Total Debt | £ 1.58B | £ 1.57B | £ 1.77B | £ 1.32B | £ 1.09B |
Net Debt | £ -1.25B | £ -658.10M | £ -268.70M | £ -52.20M | £ 86.70M |
Total Liabilities | £ 3.40B | £ 3.10B | £ 2.65B | £ 1.91B | £ 1.89B |
Stockholders Equity | £ 1.29B | £ 896.60M | £ 922.60M | £ 964.20M | £ 750.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |